project id: TCGA-HNSC; case submitter id: TCGA-BA-A4IH; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 7.9; age at index: 57; days to birth: -21094; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 21094; ajcc clinical m: M0; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 622.0; icd 10 code: C10.9; last known disease status: not reported; morphology: 8083/3; primary diagnosis: Basaloid squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tonsil, NOS; synchronous malignancy: No; tissue or organ of origin: Tonsil, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; initial weight: 380.0; oct embedded: false; preservation method: Unknown; sample id: f87efb5e-24f5-4d2b-b6b3-987bbda30e03; sample submitter id: TCGA-BA-A4IH-01A; portion id: 6f10a153-afe4-4bcc-a7ad-f97a040e6c7b; portion submitter id: TCGA-BA-A4IH-01A-11; slide id: 6ae1a129-c925-4897-a591-214157e02324; slide submitter id: TCGA-BA-A4IH-01A-01-TS1; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 15.0; percent stromal cells: 15.0; percent tumor cells: 70.0; percent tumor nuclei: 100.0; section location: TOP;